$DCTH
Delcath Systems Inc

2023 Q1 Form 10-K Financial Statement

#000119312523079836 Filed on March 27, 2023

View on sec.gov

Income Statement

Concept 2023 Q1 2022 Q4 2022
Revenue $597.0K $639.0K $2.719M
YoY Change 57.94% -69.69% -23.52%
Cost Of Revenue $181.0K $237.0K $686.0K
YoY Change 448.48% 82.31% 2.24%
Gross Profit $416.0K $402.0K $2.033M
YoY Change 20.58% -79.68% -29.51%
Gross Profit Margin 69.68% 62.91% 74.77%
Selling, General & Admin $4.165M $4.994M $17.30M
YoY Change 14.17% 65.58% 26.88%
% of Gross Profit 1001.2% 1242.29% 851.11%
Research & Development $4.576M $4.934M $18.58M
YoY Change 7.92% 36.34% 34.87%
% of Gross Profit 1100.0% 1227.36% 914.07%
Depreciation & Amortization $30.00K $34.00K $132.0K
YoY Change -3.23% 9.68% -9.59%
% of Gross Profit 7.21% 8.46% 6.49%
Operating Expenses $8.741M $9.928M $35.89M
YoY Change 10.81% 49.63% 30.9%
Operating Profit -$8.325M -$9.526M -$33.85M
YoY Change 10.37% 104.55% 38.0%
Interest Expense -$688.0K -$645.0K -$2.685M
YoY Change 6.67% -5.84% 126.39%
% of Operating Profit
Other Income/Expense, Net $13.00K $28.00K $30.00K
YoY Change -186.67% -660.0% -55.88%
Pretax Income -$9.000M -$10.14M -$36.51M
YoY Change 9.72% 89.7% 42.33%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$9.000M -$10.14M -$36.50M
YoY Change 9.72% 89.7% 42.31%
Net Earnings / Revenue -1507.54% -1587.32% -1342.41%
Basic Earnings Per Share -$0.77 -$4.12
Diluted Earnings Per Share -$0.77 -$1.03 -$4.12
COMMON SHARES
Basic Shares Outstanding 10.06M 8.598M 8.865M
Diluted Shares Outstanding 11.62M 8.865M

Balance Sheet

Concept 2023 Q1 2022 Q4 2022
SHORT-TERM ASSETS
Cash & Short-Term Investments $24.22M $7.671M $7.671M
YoY Change 48.24% -66.36% -66.36%
Cash & Equivalents $24.22M $7.671M $7.671M
Short-Term Investments $0.00
Other Short-Term Assets $2.005M $6.120M $6.120M
YoY Change -70.75% -11.23% -11.23%
Inventory $2.337M $1.998M $1.998M
Prepaid Expenses
Receivables $458.0K $366.0K $366.0K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $29.02M $16.16M $16.16M
YoY Change 14.33% -48.14% -48.14%
LONG-TERM ASSETS
Property, Plant & Equipment $1.392M $1.422M $1.707M
YoY Change -27.99% 5.49% -13.44%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $1.577M $1.707M $1.707M
YoY Change -18.42% -13.44% -13.44%
TOTAL ASSETS
Total Short-Term Assets $29.02M $16.16M $16.16M
Total Long-Term Assets $1.577M $1.707M $1.707M
Total Assets $30.60M $17.86M $17.86M
YoY Change 12.01% -46.08% -46.08%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.428M $2.018M $2.018M
YoY Change 95.33% 216.3% 216.3%
Accrued Expenses $7.120M $4.685M $4.871M
YoY Change 55.32% 14.02% 22.57%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0% -100.0% -100.0%
Long-Term Debt Due $3.770M $7.846M $7.846M
YoY Change 49.6% 1163.45% 1163.45%
Total Short-Term Liabilities $13.41M $14.74M $14.74M
YoY Change 54.83% 147.48% 147.48%
LONG-TERM LIABILITIES
Long-Term Debt $5.798M $7.842M $7.842M
YoY Change -56.43% -47.76% -47.76%
Other Long-Term Liabilities $1.158M $1.144M $1.144M
YoY Change 849.18% 452.66% 452.66%
Total Long-Term Liabilities $1.158M $1.144M $8.986M
YoY Change -91.38% -92.48% -40.95%
TOTAL LIABILITIES
Total Short-Term Liabilities $13.41M $14.74M $14.74M
Total Long-Term Liabilities $1.158M $1.144M $8.986M
Total Liabilities $25.31M $23.72M $23.72M
YoY Change 14.55% 12.04% 12.04%
SHAREHOLDERS EQUITY
Retained Earnings -$466.5M -$457.5M
YoY Change 8.67%
Common Stock $101.0K $100.0K
YoY Change 26.58%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$13.08M -$5.859M -$5.859M
YoY Change
Total Liabilities & Shareholders Equity $30.60M $17.86M $17.86M
YoY Change 12.01% -46.08% -46.08%

Cashflow Statement

Concept 2023 Q1 2022 Q4 2022
OPERATING ACTIVITIES
Net Income -$9.000M -$10.14M -$36.50M
YoY Change 9.72% 89.7% 42.31%
Depreciation, Depletion And Amortization $30.00K $34.00K $132.0K
YoY Change -3.23% 9.68% -9.59%
Cash From Operating Activities -$4.264M -$7.359M -$24.95M
YoY Change -33.11% 14.79% 10.38%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $0.00 $209.0K
YoY Change -100.0% -100.0% -246.15%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $0.00 $0.00 -$209.0K
YoY Change -100.0% -100.0% 46.15%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $714.0K
YoY Change
Cash From Financing Activities 16.69M 5.247M 10.14M
YoY Change 21.77% -51.29%
NET CHANGE
Cash From Operating Activities -4.264M -7.359M -24.95M
Cash From Investing Activities 0.000 0.000 -209.0K
Cash From Financing Activities 16.69M 5.247M 10.14M
Net Change In Cash 12.45M -2.112M -15.13M
YoY Change -292.61% 0.52% 686.03%
FREE CASH FLOW
Cash From Operating Activities -$4.264M -$7.359M -$24.95M
Capital Expenditures $0.00 $0.00 $209.0K
Free Cash Flow -$4.264M -$7.359M -$25.16M
YoY Change -32.17% 14.77% 12.01%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022 dei Entity Central Index Key
EntityCentralIndexKey
0000872912
CY2022 dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
CY2022 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2022 dei Amendment Flag
AmendmentFlag
false
CY2022 dei Document Type
DocumentType
10-K
CY2022 dei Document Annual Report
DocumentAnnualReport
true
CY2022 dei Document Period End Date
DocumentPeriodEndDate
2022-12-31
CY2022 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022 dei Document Transition Report
DocumentTransitionReport
false
CY2022 dei Entity File Number
EntityFileNumber
001-16133
CY2022 dei Entity Registrant Name
EntityRegistrantName
DELCATH SYSTEMS, INC.
CY2022 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2022 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
06-1245881
CY2022 dei Entity Address Address Line1
EntityAddressAddressLine1
1633 Broadway
CY2022 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 22C
CY2022 dei Entity Address City Or Town
EntityAddressCityOrTown
New York
CY2022 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10019
CY2022 dei City Area Code
CityAreaCode
212
CY2022 dei Local Phone Number
LocalPhoneNumber
489-2100
CY2022 dei Security12b Title
Security12bTitle
Common stock, $0.01 par value per share
CY2022 dei Trading Symbol
TradingSymbol
DCTH
CY2022 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2022 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2022 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2022 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022 dei Entity Small Business
EntitySmallBusiness
true
CY2022 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2022 dei Entity Shell Company
EntityShellCompany
false
CY2022 dei Auditor Firm
AuditorFirmId
688
CY2022 dei Auditor Name
AuditorName
Marcum LLP
CY2022 dei Auditor Location
AuditorLocation
New York, NY
CY2022Q2 dei Entity Public Float
EntityPublicFloat
31947845000
CY2023Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
10061988
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7671000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
22802000
CY2022Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
4151000
CY2021Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
4151000
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
366000
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
44000
CY2022Q4 us-gaap Inventory Net
InventoryNet
1998000
CY2021Q4 us-gaap Inventory Net
InventoryNet
1412000
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1969000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2743000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
16155000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
31152000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1422000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1348000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
285000
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
624000
CY2022Q4 us-gaap Assets
Assets
17862000
CY2021Q4 us-gaap Assets
Assets
33124000
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2018000
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
638000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4685000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4109000
CY2022Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
0
CY2021Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
170000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
186000
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
416000
CY2022Q4 us-gaap Loans Payable Current
LoansPayableCurrent
7846000
CY2021Q4 us-gaap Loans Payable Current
LoansPayableCurrent
621000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
14735000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
5954000
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1144000
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
207000
CY2022Q4 us-gaap Long Term Loans Payable
LongTermLoansPayable
3070000
CY2021Q4 us-gaap Long Term Loans Payable
LongTermLoansPayable
10372000
CY2022Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
4772000
CY2021Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
4639000
CY2022Q4 us-gaap Liabilities
Liabilities
23721000
CY2021Q4 us-gaap Liabilities
Liabilities
21172000
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
11357
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
11357
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
11357
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
11357
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
40000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
40000000
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
10046571
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
10046571
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
7906728
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
7906728
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
100000
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
79000
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
451608000
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
432831000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-457484000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-420976000
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-83000
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
18000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-5859000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
11952000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
17862000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
33124000
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2719000
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3555000
CY2022 us-gaap Cost Of Revenue
CostOfRevenue
686000
CY2021 us-gaap Cost Of Revenue
CostOfRevenue
671000
CY2022 us-gaap Gross Profit
GrossProfit
2033000
CY2021 us-gaap Gross Profit
GrossProfit
2884000
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
18583000
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
13778000
CY2022 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
17303000
CY2021 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
13637000
CY2022 us-gaap Operating Expenses
OperatingExpenses
35886000
CY2021 us-gaap Operating Expenses
OperatingExpenses
27415000
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-33853000
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-24531000
CY2022 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-2685000
CY2021 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-1186000
CY2022 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
30000
CY2021 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
68000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-36508000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-25649000
CY2022 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
101000
CY2021 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
122000
CY2022 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-36407000
CY2021 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-25527000
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-4.12
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-4.12
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-3.59
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-3.59
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
8864615
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8864615
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7145754
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7145754
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
11952000
CY2022 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
7941000
CY2022 dcth Issuance Of Common Stock And Pre Funded Warrants In Private Placement
IssuanceOfCommonStockAndPreFundedWarrantsInPrivatePlacement
10857000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-36508000
CY2022 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-101000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-5859000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
22078000
CY2021 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
7832000
CY2021 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
57000
CY2021 dcth Stock Issued During Period Value Exercise Of Warrants For Common Stock
StockIssuedDuringPeriodValueExerciseOfWarrantsForCommonStock
2458000
CY2021 dcth Proceeds From Warrant
ProceedsFromWarrant
-1171000
CY2021 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
44000
CY2021 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
4000
CY2021 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
3923000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-25649000
CY2021 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
122000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
11952000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-36508000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-25649000
CY2022 dcth Stock Option Compensation Income Expense
StockOptionCompensationIncomeExpense
7941000
CY2021 dcth Stock Option Compensation Income Expense
StockOptionCompensationIncomeExpense
7832000
CY2022 us-gaap Depreciation
Depreciation
132000
CY2021 us-gaap Depreciation
Depreciation
146000
CY2022 dcth Amortization Of Right Of Use Assets
AmortizationOfRightOfUseAssets
443000
CY2021 dcth Amortization Of Right Of Use Assets
AmortizationOfRightOfUseAssets
322000
CY2022 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
768000
CY2021 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
323000
CY2022 us-gaap Paid In Kind Interest
PaidInKindInterest
160000
CY2021 us-gaap Paid In Kind Interest
PaidInKindInterest
186000
CY2022 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-774000
CY2021 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-813000
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
322000
CY2021 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-13000
CY2022 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
587000
CY2021 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
557000
CY2022 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1798000
CY2021 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-3284000
CY2022 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
621000
CY2021 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-322000
CY2022 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-170000
CY2021 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-2427000
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-24950000
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-22604000
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
209000
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
143000
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-209000
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-143000
CY2022 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
10857000
CY2021 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
0
CY2022 dcth Proceeds From Issuance Of Atm Offering
ProceedsFromIssuanceOfAtmOffering
CY2021 dcth Proceeds From Issuance Of Atm Offering
ProceedsFromIssuanceOfAtmOffering
3923000
CY2022 dcth Net Proceeds From Debt Financing
NetProceedsFromDebtFinancing
0
CY2021 dcth Net Proceeds From Debt Financing
NetProceedsFromDebtFinancing
14437000
CY2022 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
CY2021 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
4000
CY2022 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
0
CY2021 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
2458000
CY2022 us-gaap Repayments Of Debt
RepaymentsOfDebt
714000
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
10143000
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
20822000
CY2022 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-115000
CY2021 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
122000
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-15131000
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1803000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
26953000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
28756000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
11822000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
26953000
CY2022Q4 us-gaap Cash
Cash
7671000
CY2021Q4 us-gaap Cash
Cash
22802000
CY2022Q4 us-gaap Restricted Cash
RestrictedCash
4151000
CY2021Q4 us-gaap Restricted Cash
RestrictedCash
4151000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
11822000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
26953000
CY2022 us-gaap Interest Paid Net
InterestPaidNet
1873000
CY2021 us-gaap Interest Paid Net
InterestPaidNet
681000
CY2022 dcth Shares Settled For Services
SharesSettledForServices
0
CY2021 dcth Shares Settled For Services
SharesSettledForServices
57000
CY2022 dcth Proceeds Allocated To Warrant
ProceedsAllocatedToWarrant
0
CY2021 dcth Proceeds Allocated To Warrant
ProceedsAllocatedToWarrant
1171000
CY2021 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
886000
CY2022 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
86000
CY2021 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-36500000
CY2022 dcth Net Cash Provided By The Used In Operating Activities
NetCashProvidedByTheUsedInOperatingActivities
-25000000
CY2022 us-gaap Basis Of Accounting
BasisOfAccounting
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:3%;vertical-align:top;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(2)</div></div></td> <td style="font-size:8pt;width:1%;vertical-align:top"> </td> <td style="vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Basis of Consolidated Financial Statement Presentation </div></div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The accounting and financial reporting policies of the Company conform to generally accepted accounting principles in the United States of America (“GAAP”). The preparation of consolidated financial statements in conformity with GAAP requires management to make assumptions and estimates that impact the amounts reported in the Company’s consolidated financial statements. The consolidated financial statements include the accounts of all entities controlled by the Company. All significant inter-company accounts and transactions are eliminated. </div><div style="font-size:18pt;margin-top:0pt;margin-bottom:0pt"> </div>
CY2021Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
767000
CY2022Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
1102000
CY2021Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
645000
CY2022Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
133000
CY2022 us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Use of Estimates </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company bases its estimates and judgments on historical experience and on various other assumptions that it believes are reasonable under the circumstances. The amounts of assets and liabilities reported in the Company’s consolidated balance sheets and the amount of revenues and expenses reported for each of the periods presented are affected by estimates and assumptions, which are used for, but not limited to, the accounting for valuation of warrants, stock-based compensation, valuation of inventory, impairment of long-lived assets, income taxes and operating expense accruals. Such assumptions and estimates are subject to change in the future as additional information becomes available or as circumstances are modified. Actual results could differ from these estimates.</div>
CY2022 dcth Maximum Period Of Investments With Original Maturities From Date Of Acquisition To Be Cash Equivalents
MaximumPeriodOfInvestmentsWithOriginalMaturitiesFromDateOfAcquisitionToBeCashEquivalents
P3M
CY2021Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
0
CY2022Q4 us-gaap Inventory Net
InventoryNet
1998000
CY2021Q4 us-gaap Inventory Net
InventoryNet
1412000
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
40000000
CY2022 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7469547
CY2021 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6966955
CY2022Q1 dcth Impact Of Correction Of Share Based Compensation On Net Income Loss
ImpactOfCorrectionOfShareBasedCompensationOnNetIncomeLoss
797000
CY2022Q2 dcth Impact Of Correction Of Share Based Compensation On Net Income Loss
ImpactOfCorrectionOfShareBasedCompensationOnNetIncomeLoss
502000
CY2022Q3 dcth Impact Of Correction Of Share Based Compensation On Net Income Loss
ImpactOfCorrectionOfShareBasedCompensationOnNetIncomeLoss
372000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7671000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
22802000
CY2022Q4 dcth Loan Agreement Restricted Cash
LoanAgreementRestrictedCash
4000000
CY2021Q4 dcth Loan Agreement Restricted Cash
LoanAgreementRestrictedCash
4000000
CY2022Q4 dcth Letters Of Credit Restricted Cash
LettersOfCreditRestrictedCash
101000
CY2021Q4 dcth Letters Of Credit Restricted Cash
LettersOfCreditRestrictedCash
101000
CY2022Q4 dcth Security For Credit Cards Restricted Cash
SecurityForCreditCardsRestrictedCash
50000
CY2021Q4 dcth Security For Credit Cards Restricted Cash
SecurityForCreditCardsRestrictedCash
50000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
11822000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
26953000
CY2022Q4 dcth Letters Of Credit Restricted Cash
LettersOfCreditRestrictedCash
101000
CY2022 dcth Lessee Operating Sublease Expiry Term
LesseeOperatingSubleaseExpiryTerm
2023-05
CY2022Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
763000
CY2022Q4 dcth Prepaid Clinical Trial Expenses Current
PrepaidClinicalTrialExpensesCurrent
1630000
CY2021Q4 dcth Prepaid Clinical Trial Expenses Current
PrepaidClinicalTrialExpensesCurrent
1630000
CY2022Q4 us-gaap Prepaid Insurance
PrepaidInsurance
123000
CY2021Q4 us-gaap Prepaid Insurance
PrepaidInsurance
890000
CY2022Q4 dcth Prepaid Professional Services Current
PrepaidProfessionalServicesCurrent
121000
CY2021Q4 dcth Prepaid Professional Services Current
PrepaidProfessionalServicesCurrent
15000
CY2022Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
95000
CY2021Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
208000
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1969000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2743000
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
6353000
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
6173000
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
4931000
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
4825000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1422000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1348000
CY2022 dcth Depreciationexpense
Depreciationexpense
132000
CY2021 dcth Depreciationexpense
Depreciationexpense
146000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
40000000
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q4 dcth Accrued Clinical Expenses Current
AccruedClinicalExpensesCurrent
1470000
CY2021Q4 dcth Accrued Clinical Expenses Current
AccruedClinicalExpensesCurrent
1517000
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1040000
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
893000
CY2022Q4 dcth Short Term Fnancing
ShortTermFnancing
0
CY2021Q4 dcth Short Term Fnancing
ShortTermFnancing
551000
CY2022Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1087000
CY2021Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
603000
CY2022Q4 us-gaap Interest Payable Current
InterestPayableCurrent
553000
CY2021Q4 us-gaap Interest Payable Current
InterestPayableCurrent
393000
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
535000
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
152000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4685000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4109000
CY2022Q4 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P12M
CY2022 us-gaap Operating Lease Cost
OperatingLeaseCost
443000
CY2022 us-gaap Operating Lease Payments
OperatingLeasePayments
443000
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
192000
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
37000
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
37000
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
22000
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
288000
CY2022Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
20000
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
268000
CY2022Q4 dcth Notes And Loans Payable Gross Non Current
NotesAndLoansPayableGrossNonCurrent
3353000
CY2022Q4 dcth Discount On Notes And Loans Payable Nonurrent
DiscountOnNotesAndLoansPayableNonurrent
-284000
CY2022Q4 us-gaap Long Term Loans Payable
LongTermLoansPayable
3070000
CY2021Q4 dcth Notes And Loans Payable Gross Non Current
NotesAndLoansPayableGrossNonCurrent
11924000
CY2021Q4 dcth Discount On Notes And Loans Payable Nonurrent
DiscountOnNotesAndLoansPayableNonurrent
-1552000
CY2021Q4 us-gaap Long Term Loans Payable
LongTermLoansPayable
10372000
CY2022Q4 dcth Notes And Loans Payable Gross
NotesAndLoansPayableGross
5000000
CY2022Q4 dcth Discount On Notes And Loans Payable
DiscountOnNotesAndLoansPayable
-228000
CY2022Q4 dcth Notes And Loans Payable Net
NotesAndLoansPayableNet
4772000
CY2021Q4 dcth Notes And Loans Payable Gross
NotesAndLoansPayableGross
5000000
CY2021Q4 dcth Discount On Notes And Loans Payable
DiscountOnNotesAndLoansPayable
-361000
CY2021Q4 dcth Notes And Loans Payable Net
NotesAndLoansPayableNet
4639000
CY2022 dcth Percentage Of Final Payment Included In Gross Amount
PercentageOfFinalPaymentIncludedInGrossAmount
0.0425
CY2022 dcth Final Payment
FinalPayment
637500
CY2022Q4 us-gaap Loans Payable
LoansPayable
11923000
CY2022Q4 us-gaap Notes Payable
NotesPayable
5000000
CY2022Q4 us-gaap Notes And Loans Payable
NotesAndLoansPayable
16923000
CY2022 us-gaap Interest Expense Borrowings
InterestExpenseBorrowings
1900000
CY2022 dcth Avenue Warrant Value
AvenueWarrantValue
1300000
CY2021Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y25D
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.87
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0077
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2021 us-gaap Conversion Of Stock Shares Issued1
ConversionOfStockSharesIssued1
927379
CY2022 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
0
CY2021Q1 dcth Issue Of Unregistered Common Stock For Advisory Services
IssueOfUnregisteredCommonStockForAdvisoryServices
2636
CY2021 dcth Stock Issued During Period Shares Associated Other Warrants
StockIssuedDuringPeriodSharesAssociatedOtherWarrants
465173
CY2021 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
2500000
CY2022Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
2475000
CY2020Q4 dcth Number Of Common Shares Remained Available To Be Issued
NumberOfCommonSharesRemainedAvailableToBeIssued
870508
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
6.05
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
9.74
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1732460
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
11.69
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
702583
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
6.74
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
65690
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
10.43
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
134301
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
9.59
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2235052
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
10.3
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
36000
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1316515
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
11.13
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P7Y7M6D
CY2022Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
0
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2235052
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P7Y7M6D
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1316515
CY2022Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
2800000
CY2022 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y7M6D
CY2022 dcth Share Based Compensation Income Expense
ShareBasedCompensationIncomeExpense
7900000
CY2021 dcth Share Based Compensation Income Expense
ShareBasedCompensationIncomeExpense
7800000
CY2022 dcth Share Based Compensation Income Expense
ShareBasedCompensationIncomeExpense
7941000
CY2021 dcth Share Based Compensation Income Expense
ShareBasedCompensationIncomeExpense
7832000
CY2021Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
3894498
CY2021Q4 dcth Class Of Warrant Or Right Weighted Average Exercise Price
ClassOfWarrantOrRightWeightedAverageExercisePrice
9.27
CY2022 dcth Class Of Warrant Or Right Issued
ClassOfWarrantOrRightIssued
1258793
CY2022 dcth Class Of Warrant Or Right Weighted Average Exercise Price Issued
ClassOfWarrantOrRightWeightedAverageExercisePriceIssued
0.01
CY2022Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
5153291
CY2022Q4 dcth Class Of Warrant Or Right Weighted Average Exercise Price
ClassOfWarrantOrRightWeightedAverageExercisePrice
7.01
CY2022 dcth Class Of Warrant Or Right Weighted Average Remaining Contractual Term
ClassOfWarrantOrRightWeightedAverageRemainingContractualTerm
P2Y9M18D
CY2022Q4 dcth Class Of Warrant Or Right Exercisable
ClassOfWarrantOrRightExercisable
5153291
CY2022Q4 dcth Class Of Warrant Or Right Exercisable Weighted Average Exercise Price
ClassOfWarrantOrRightExercisableWeightedAverageExercisePrice
7.01
CY2022 dcth Class Of Warrant Or Right Exercisable Weighted Average Remaining Contractual Term
ClassOfWarrantOrRightExercisableWeightedAverageRemainingContractualTerm
P2Y9M18D
CY2021 dcth Income Tax Rate Reconciliation State Operating Loss Carryforwards
IncomeTaxRateReconciliationStateOperatingLossCarryforwards
-2799000
CY2022 dcth Income Tax Reconciliation Branch Income
IncomeTaxReconciliationBranchIncome
385000
CY2022Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
5153291
CY2022 dcth Class Of Warrant Or Right Weighted Average Remaining Contractual Term
ClassOfWarrantOrRightWeightedAverageRemainingContractualTerm
P2Y9M18D
CY2022Q4 dcth Class Of Warrant Or Right Exercisable
ClassOfWarrantOrRightExercisable
5153291
CY2021Q4 dcth Milestone Payment Unpaid
MilestonePaymentUnpaid
1000000
CY2022 dcth Revenue Recognition
RevenueRecognition
1700000
CY2021 dcth Provision For Income Tax
ProvisionForIncomeTax
0
CY2022 dcth Provision For Income Tax
ProvisionForIncomeTax
0
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-34547000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-25881000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-1960000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
232000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-36507000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-25649000
CY2022 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
7666000
CY2021 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
5386000
CY2022 dcth Income Tax Reconciliation Nondeductible Expense Interest
IncomeTaxReconciliationNondeductibleExpenseInterest
-139000
CY2021 dcth Income Tax Reconciliation Nondeductible Expense Interest
IncomeTaxReconciliationNondeductibleExpenseInterest
-39000
CY2022 dcth Income Tax Rate Reconciliation State Operating Loss Carryforwards
IncomeTaxRateReconciliationStateOperatingLossCarryforwards
0
CY2021 dcth Income Tax Reconciliation Branch Income
IncomeTaxReconciliationBranchIncome
-229000
CY2022 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
531000
CY2021 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-311000
CY2022 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
-165000
CY2021 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
-27000
CY2022 dcth Valuation Allowance Deferred Tax Asset Change In Amount Charged To Costs And Expenses
ValuationAllowanceDeferredTaxAssetChangeInAmountChargedToCostsAndExpenses
9221000
CY2021 dcth Valuation Allowance Deferred Tax Asset Change In Amount Charged To Costs And Expenses
ValuationAllowanceDeferredTaxAssetChangeInAmountChargedToCostsAndExpenses
2114000
CY2022 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
-752000
CY2021 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
-446000
CY2022 us-gaap Income Tax Reconciliation Nondeductible Expense Research And Development
IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment
708000
CY2021 us-gaap Income Tax Reconciliation Nondeductible Expense Research And Development
IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment
375000
CY2022 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
987000
CY2021 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
204000
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation
2772000
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation
1777000
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
197000
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
29000
CY2022Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
1429000
CY2021Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
721000
CY2022Q4 dcth Deferred Tax Assets Lease Obligations
DeferredTaxAssetsLeaseObligations
38000
CY2021Q4 dcth Deferred Tax Assets Lease Obligations
DeferredTaxAssetsLeaseObligations
107000
CY2022Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
160000
CY2021Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
89000
CY2022Q4 dcth Deferred Tax Assets Deferred Expense Capitalized Research And Development Costs
DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopmentCosts
3203000
CY2021Q4 dcth Deferred Tax Assets Deferred Expense Capitalized Research And Development Costs
DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopmentCosts
0
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
24595000
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
20520000
CY2022Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
32394000
CY2021Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
23243000
CY2022Q4 dcth Deferred Tax Liabilities Right Of Use Asset
DeferredTaxLiabilitiesRightOfUseAsset
50000
CY2021Q4 dcth Deferred Tax Liabilities Right Of Use Asset
DeferredTaxLiabilitiesRightOfUseAsset
118000
CY2022Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
50000
CY2021Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
118000
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
32344000
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
23125000
CY2022Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0
CY2021Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0
CY2022Q4 dcth Valuation Allowance Deferred Tax Asset Percentage
ValuationAllowanceDeferredTaxAssetPercentage
1
CY2022 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
-9200000
CY2021 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
-1800000
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
23125000
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
21332000
CY2022 dcth Valuation Allowance Deferred Tax Asset Change In Amount Charged To Costs And Expenses
ValuationAllowanceDeferredTaxAssetChangeInAmountChargedToCostsAndExpenses
9221000
CY2021 dcth Valuation Allowance Deferred Tax Asset Change In Amount Charged To Costs And Expenses
ValuationAllowanceDeferredTaxAssetChangeInAmountChargedToCostsAndExpenses
2114000
CY2022 dcth Valuation Allowance Deferred Tax Asset Change In Amount Charged To Other Comprehensive Income
ValuationAllowanceDeferredTaxAssetChangeInAmountChargedToOtherComprehensiveIncome
-2000
CY2021 dcth Valuation Allowance Deferred Tax Asset Change In Amount Charged To Other Comprehensive Income
ValuationAllowanceDeferredTaxAssetChangeInAmountChargedToOtherComprehensiveIncome
-321000
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
32344000
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
23125000
CY2021Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
0
CY2022 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
1168000
CY2022 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease
112000
CY2022Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
1280000
CY2022Q4 dcth Contingent Liabilities Fair Value
ContingentLiabilitiesFairValue
1280000
CY2022Q4 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
1280000

Files In Submission

Name View Source Status
0001193125-23-079836-index-headers.html Edgar Link pending
0001193125-23-079836-index.html Edgar Link pending
0001193125-23-079836.txt Edgar Link pending
0001193125-23-079836-xbrl.zip Edgar Link pending
d449666d10k.htm Edgar Link pending
d449666dex21.htm Edgar Link pending
d449666dex231.htm Edgar Link pending
d449666dex311.htm Edgar Link pending
d449666dex312.htm Edgar Link pending
d449666dex321.htm Edgar Link pending
d449666dex322.htm Edgar Link pending
d449666dex412.htm Edgar Link pending
dcth-20221231.xsd Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
dcth-20221231_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
dcth-20221231_lab.xml Edgar Link unprocessable
d449666d10k_htm.xml Edgar Link completed
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
dcth-20221231_cal.xml Edgar Link unprocessable
dcth-20221231_def.xml Edgar Link unprocessable